Thursday, 22 July 2010
Amanda Ellis
HEXIMA has gained 39% after Acrux non-executive chairman and Starpharma non-executive director Ross Dobinson was appointed executive chairman of the agricultural biotechnology company.
You are not logged in or not authorised to view this page.
Get Your FREE 30 Day Trial Now!
|
|
|
OR
Click here to read the rest of today's news stories.
| 
